[artículo] 
inAnnual progress in child psychiatry and child develoment > Año 1990 [17/11/2020] . - pp. 481-497

Título :	A double-blind placebo controlled study of desipramine in the treatment of ADD : I. Efficacy
Tipo de documento:	texto impreso
Autores:	Joseph Biederman, Autor ; Ross J. Baldessarini, Autor ; Virginia Wright, Autor
Fecha de publicación:	2020
Artículo en la página:	pp. 481-497
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Trastorno por déficit de atención e hiperactividad, Desipramina, Relación dosis-respuesta, Ensayos controlados aleatorios.
Resumen:	The tricyclic antidepressant drug desipramine (DMI) was evaluated in the treatment of young patients with attention deficit disorder with hyperactivity (ADDH) in an unselected sample of 62 clinically referred patients, 43 (69%) of whom previously responded poorly to psychostimulant treatment. The 42 children and 20 adolescents were assigned randomly to receive DMI (N = 31) or placebo (N = 31) for up to 6 weeks in a parallel groups, double-blind study.
Link:	./index.php?lvl=notice_display&id=25265

[artículo] A double-blind placebo controlled study of desipramine in the treatment of ADD : I. Efficacy [texto impreso] / Joseph Biederman, Autor ; Ross J. Baldessarini, Autor ; Virginia Wright, Autor . - 2020 . - pp. 481-497.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Annual progress in child psychiatry and child develoment > Año 1990 [17/11/2020] . - pp. 481-497

Palabras clave:	Trastorno por déficit de atención e hiperactividad, Desipramina, Relación dosis-respuesta, Ensayos controlados aleatorios.
Resumen:	The tricyclic antidepressant drug desipramine (DMI) was evaluated in the treatment of young patients with attention deficit disorder with hyperactivity (ADDH) in an unselected sample of 62 clinically referred patients, 43 (69%) of whom previously responded poorly to psychostimulant treatment. The 42 children and 20 adolescents were assigned randomly to receive DMI (N = 31) or placebo (N = 31) for up to 6 weeks in a parallel groups, double-blind study.
Link:	./index.php?lvl=notice_display&id=25265